$AIMD

lee ting-chuan sold $14K of AIMD

lee ting-chuan sold 9,000 shares of Ainos, Inc. (AIMD) at $1.56 on 2026-05-21.

Original reporting
SEC EDGAR · lee ting-chuan
Published May 26, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIMD
Bearish
medium confidence
Mentioned
$AIMD
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIMDBearishMed
01

Why it matters

Traders may reassess near-term sentiment, but the disclosure lacks accompanying operational or financial updates.

02

Market read

Insider selling disclosure can affect micro-sentiment, though the dollar value is modest and no 10b5-1 plan is cited.

03

What to watch

Single-trade size ($14.0k) is small relative to typical market caps; without follow-on insider buys/sales or operational news, signal-to-noise is low.

Relevance 8/10Timing: Immediate (filed 2026-05-26; trade dated 2026-05-21) for short-term sentiment/positioning.

Background

The article is an SEC Form 4 insider transaction disclosure for Ainos, Inc. (AIMD).

Company-level read

Ticker impact

$AIMDBearishMedium confidence
Context

Ainos director lee ting-chuan sold 9,000 shares in an open-market transaction ($1.56/share) disclosed via SEC Form 4.

Expected impact

Likely modest downward pressure or increased volatility around the filing; no strong directional move expected solely from this trade.

Evidence & confidence

This is a single director sale (direct holdings reduced to 926,707) with no 10b5-1 plan stated; insider sales often have mixed interpretation absent broader company catalysts.

Market effects

Minimal—this is company-specific insider activity with no sector-wide catalyst mentioned.

None indicated; filing is US SEC EDGAR with no geographic demand/supply shock.

None indicated; no international deal/regulatory development referenced.

Counterpoint

The sale could be routine liquidity/portfolio rebalancing; the absence of a stated 10b5-1 plan doesn’t necessarily imply negative fundamentals.

Key entities

  • Ainos, Inc.

    Subject of the insider transaction disclosure; director sold shares open-market.

  • lee ting-chuan

    Director who sold 9,000 shares at $1.56/share on 2026-05-21.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIMDHigh

Ainos Shares Rise 6.9% After Receiving Initial AI Nose Semiconductor Orders

Ainos Inc. (AIMD) shares rose 6.9% after receiving initial commercial orders for its AI Nose platform from a semiconductor manufacturer. The orders follow validation activities and represent a shift to commercial deployment. The company expects revenue from these orders in the second half of 2026. Ainos also reported its chemical dataset has surpassed one billion records, up from 878 million in August.

$AIMDHigh

Ainos stock jumps on AI Nose orders from semiconductor sector

Ainos Inc (AIMD) shares rose 6.9% premarket after receiving initial commercial orders for its AI Nose platform from a semiconductor manufacturer. The orders mark a shift to commercial deployment, with revenue expected from late 2026. The company also announced its real-world chemical dataset surpassed 1 billion records, up from 878 million in August. AIMD's technology is used in semiconductor manufacturing for chemical perception and data collection.

$AIMDLow

Ainos, Inc. (AIMD): Results of Operations and Financial Condition

Ainos, Inc. (AIMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Company”) today announced results for the second quarter en

$AIMDMed

Ainos, Inc.: VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Ainos, Inc. (NASDAQ:AIMD) said VASRO GmbH highlighted its AI Nose platform’s expansion into live emergency department operations. VASRO reports a research program at an Asia academic medical center to generate 2,500+ hours of emergency-department environmental scent data for overcrowding early warning and respiratory infection risk analysis. The initiative broadens evaluations beyond industrial settings and supports Ainos’ Smell Language Model development.